Swedish Orphan Biovitrum
MA - WalthamBiotechnology
Focus: Swedish Orphan Biovitrum (Sobi) is a specialty biotech company headquartered in Waltham, MA, focused on rare diseases, oncology, immunology, and hematology through a portfolio of biologics. The company is publicly traded and operates a mixed model of mature marketed products and early-to-mid stage pipeline programs.
Profile data last refreshed 13h ago · AI intelligence enriched 1w ago
Funding Stage
PUBLIC
Open Jobs
69+27 this month
Hot — 58 jobs added in 30d
Net +27 (58 new, 31 removed). Aggressive expansion phase.
Should You Work at Swedish Orphan Biovitrum?
AI assessmentSobi offers rare-disease specialization and commercial growth opportunity, but extreme KINERET dependence and thin pipeline create significant medium-term restructuring risk.
Why Work Here
- Heavy commercial hiring (20 of 73 active roles) signals aggressive market-building around core franchise, offering entry into established sales and marketing operations
Data completeness
6/9 — Partial
Company HealthSolid
Pipeline
Early-stage
50 total
LOE Risk
Protected
No near-term cliffs
Hiring
Stable
Automated analysis based on publicly available data (FDA, SEC, ClinicalTrials.gov). May be incomplete or delayed. This score does not reflect insider knowledge and should not be used as the sole basis for investment or employment decisions.
Key Products
$28M Part DDeclining
LOE Approaching
Flagship revenue driver (99% of company revenue) but patent expiry approaching with no disclosed LOE date, creating acute business model risk.
Help build intelligence for Swedish Orphan Biovitrum
No one has shared interview or compensation data for this company yet. You'll earn 7 days of Pro access.
Data Sources
- Drug label: DailyMed / FDA
- Clinical trials: ClinicalTrials.gov
- Patent data: FDA Orange Book
- Spending data: CMS Medicare
The information on this page is for informational purposes only and should not be used as a substitute for professional medical advice. Drug information is sourced from FDA, DailyMed, and other government databases. Adverse event data from FAERS does not establish causation. Always consult a healthcare professional for medical decisions.